These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 4276659)

  • 1. Proceedings: Turnover of biogenic amines after acute and chronic morphine treatment in rats.
    Theiss P; Papeschi R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R98. PubMed ID: 4276659
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin and dopamine turnover after acute and chronic morphine administration.
    Papeschi R; Theiss P; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1017-9. PubMed ID: 4408355
    [No Abstract]   [Full Text] [Related]  

  • 3. Biogenic amines and narcotic effects. II. Serotonin turnover in the rat after acute and chronic morphine administration.
    Yarbrough GG; Buxbaum DM; Sanders-Bush E
    J Pharmacol Exp Ther; 1973 May; 185(2):328-35. PubMed ID: 4703826
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between analgesia and turnover of brain biogenic amines.
    Bensemana D; Gascon AL
    Can J Physiol Pharmacol; 1978 Oct; 56(5):721-30. PubMed ID: 709413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines.
    Nakanishi M; Setoguchi M
    Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010
    [No Abstract]   [Full Text] [Related]  

  • 6. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of morphine on the turnover of brain catecholamines and serotonin in rats-acute morphine administration.
    Papeschi R; Theiss P; Herz A
    Eur J Pharmacol; 1975 Dec; 34(2):253-61. PubMed ID: 791658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of morphine on the turnover of brain catecholamines and serotonin in rats-chronic morphine administration.
    Theiss P; Papeschi R; Herz A
    Eur J Pharmacol; 1975 Dec; 34(2):263-71. PubMed ID: 791659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
    Davis JN; Carlsson A
    J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of methiothepin on cerebral monoamine neurons.
    Lloyd KG; Bartholini G
    Adv Biochem Psychopharmacol; 1974; 10():305-9. PubMed ID: 4846546
    [No Abstract]   [Full Text] [Related]  

  • 12. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biogenic amines and their metabolites in brain tumor tissue].
    Kmieciak-Kołada K; Majchrzak H; Herman Z; Wencel T
    Neurol Neurochir Pol; 1984; 18(5):441-4. PubMed ID: 6084819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of the acute electroencephalographic and behavioral effects of morphine in the rat by depletion of brain biogenic amines.
    Colasanti B; Khazan N
    Neuropharmacology; 1973 May; 12(5):463-9. PubMed ID: 4267733
    [No Abstract]   [Full Text] [Related]  

  • 15. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of butorphanol and its metabolites on the levels of monoamines and their metabolites in the rat brain.
    Niwa M; Nose T; Nozaki M; Tsurumi K; Fujimura H
    Jpn J Pharmacol; 1985 Dec; 39(4):515-28. PubMed ID: 2419614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 20. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
    Buxbaum DM; Yarbrough GG; Carter ME
    J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.